ST6GALNAC1 antibody [N2C2], Internal

GeneTex

ST6GALNAC1 antibody [N2C2], Internal

9

Western Blot

Research Use Only

Polyclonal

1 mg/ml

Unconjugated

ST6GALNAC1

ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1

alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1; GalNAc alpha-2, 6-sialyltransferase I, long form; galNAc alpha-2,6-sialyltransferase I; HSY11339; sialyltransferase 7 ((alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl galactosaminide alpha-2,6-sialyltransferase) A; sialyltransferase 7A; SIAT7A; SIAT7-A; ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1; ST6 GalNAc alpha-2,6-sialyltransferase 1; ST6GalNAc I; ST6GALNAC1, alpha-2,6-sialyltransferase 1; ST6GalNAcI; STYI

Rabbit

IgG

Glycosylation of proteins affects cell-cell interaction, interactions with the matrix, and the functions of intracellular molecules. ST6GALNAC1 transfers a sialic acid, N-acetylneuraminic acid (NeuAc), in an alpha-2,6 linkage to O-linked GalNAc residues. The cancer-associated sialyl-Tn (sTn) antigen is formed by ST6GALNAC1-catalyzed sialylation of GalNAc residues on mucins (Ikehara et al., 1999 [PubMed 10536037]; Sewell et al., 2006 [PubMed 16319059]).[supplied by OMIM]

Human

2°C to 8°C,-20°C or -80°C

12352203